John S. Senn

1.2k total citations · 1 hit paper
35 papers, 995 citations indexed

About

John S. Senn is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, John S. Senn has authored 35 papers receiving a total of 995 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 8 papers in Genetics and 7 papers in Molecular Biology. Recurrent topics in John S. Senn's work include Acute Myeloid Leukemia Research (16 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Erythrocyte Function and Pathophysiology (4 papers). John S. Senn is often cited by papers focused on Acute Myeloid Leukemia Research (16 papers), Chronic Myeloid Leukemia Treatments (5 papers) and Erythrocyte Function and Pathophysiology (4 papers). John S. Senn collaborates with scholars based in Canada, India and Brazil. John S. Senn's co-authors include E. A. McCulloch, J. E. Till, Norman N. Iscove, P. H. Pinkerton, Gerald B. Price, Hans A. Messner, E. Richard Stanley, Jean B. Robinson, Peter H. Pinkerton and Tak W. Mak and has published in prestigious journals such as The Lancet, Blood and British Journal of Cancer.

In The Last Decade

John S. Senn

35 papers receiving 851 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Colony Formation by Normal and Leukemic Human Marrow Cells in Culture: Effect of Conditioned Medium From Human Leukocytes

1971 425 citations Norman N. Iscove, John S. Senn et al. Blood profile →

Peers

Countries citing papers authored by John S. Senn

Since Specialization

Citations

This map shows the geographic impact of John S. Senn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John S. Senn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John S. Senn more than expected).

Fields of papers citing papers by John S. Senn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John S. Senn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John S. Senn. The network helps show where John S. Senn may publish in the future.

Co-authorship network of co-authors of John S. Senn

This figure shows the co-authorship network connecting the top 25 collaborators of John S. Senn. A scholar is included among the top collaborators of John S. Senn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John S. Senn. John S. Senn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Risk-Adapted Therapy for Clinical Stage I–II Hodgkin's Disease: 7-Year Results of Radiotherapy Alone for Low-Risk Disease, and ABVD and Radiotherapy for High-Risk Disease 2000 ·Clinical Oncology ·Robert G. MacKenzie, E. Franssen, Rebecca Wong, Carol Sawka, N. L. Berinstein, D. H. Cowan, John S. Senn, P Poldre	4
2	The Health Care Ethics Consultant 1996 ·Bioethics ·John S. Senn	1
3	Foregoing renal dialysis: A case study and review of ethical issues 1996 ·American Journal of Kidney Diseases ·Sheldon W. Tobe, John S. Senn	3
4	Myelody splastic Syndrome with Prolonged Reticulocyte Survival Mimicking Hemolytic Disease 1994 ·American Journal of Clinical Pathology ·Graham D. Sher, Peter H. Pinkerton, Mahmoud Ali, John S. Senn	4
5	Writing "no-CPR" orders: must resuscitation always be offered? 1994 ·PubMed ·John S. Senn	2
6	Deletion of the long arm of chromosome 5 in essential thrombocythemia 1992 ·Cancer Genetics and Cytogenetics ·Marciano D. Reis, Graham D. Sher, (unknown), Ian D. Dubé, John S. Senn, Peter H. Pinkerton	9
7	“Jumping” translocations involving band 3q13.3 in a case of acute monocytic leukemia 1991 ·Cancer Genetics and Cytogenetics ·Marciano D. Reis, Ian D. Dubé, Peter H. Pinkerton, (unknown), Jean B. Robinson, (unknown), John S. Senn	32
8	Towards a definition of the dying patient: a response to Baylis. 1990 ·Europe PMC (PubMed Central) ·Robert F. Buckman, John S. Senn	1
9	Trisomy 14q in myelodysplastic syndromes 1990 ·Cancer Genetics and Cytogenetics ·P. H. Pinkerton, (unknown), ID Dube, John S. Senn	14
10	Acquisition of additional primary chromosome abnormalities in the course of karyotype evolution in a case of FAB-M2 acute leukemia 1989 ·Cancer Genetics and Cytogenetics ·(unknown), (unknown), Peter H. Pinkerton, John S. Senn	6
11	Allopurinol hypersensitivity in a patient with coexistent systemic lupus erythematosus and tophaceous gout. 1988 ·PubMed ·(unknown), Adel G. Fam, Thomas W. Paton, John S. Senn	9
12	Multiple myeloma with initial presentation in the jaw: a clinical‐pathologic discussion 1985 ·Journal of Oral Pathology and Medicine ·John S. Senn, (unknown), (unknown), Edward E. Kassel, J. H. P. Main	3
13	Chronic myeloid leukemia with a Philadelphia chromosome involving a t(21;22) 1984 ·Cancer Genetics and Cytogenetics ·P. H. Pinkerton, (unknown), John S. Senn	5
14	Idiopathic acquired sideroblastic anaemia transforming to acute myelosclerosis. 1984 ·Journal of Clinical Pathology ·Alison C. Bested, Guang‐Shing Cheng, P. H. Pinkerton, Olufemi Kassim, John S. Senn	1
15	Assessment of Human Pluripotent Hemopoietic Progenitors and Leukemic Blast-Forming Cells in Culture 1981 ·Hämatologie und Bluttransfusion ·H. A. Messner, AA Fauser, RN Buick, Linda Chang, (unknown), (unknown), John S. Senn, E. A. McCulloch	3
16	An Approach to Human Preleukemia Using Cell Culture Studies 1977 ·PubMed ·John S. Senn, Gerald B. Price, Tak W. Mak, E. A. McCulloch	7
17	Human preleukaemia cell culture studies in sideroblastic anaemia 1976 ·British Journal of Cancer ·John S. Senn, P. H. Pinkerton, Gerald B. Price, Tak W. Mak, E. A. McCulloch	25
18	The Heterogeneity of Cell Culture Findings in Patients with Acute Myeloblastic Leukemia 1973 ·PubMed ·D. H. Cowan, H. A. Messner, John S. Senn, E. A. McCulloch	1
19	Colony Formation by Normal and Leukemic Human Marrow Cells in Culture: Effect of Conditioned Medium From Human Leukocytes breakdown → 1971 ·Blood ·Norman N. Iscove, John S. Senn, J. E. Till, E. A. McCulloch	425
20	COMPARISON OF COLONY-FORMING ABILITY OF NORMAL AND LEUKÆMIC HUMAN MARROW IN CELL CULTURE 1967 ·The Lancet ·John S. Senn, E. A. McCulloch, J. E. Till	97

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact